SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 2152360

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2152360

AI-assisted Radiation Therapy Planning Software Market Size, Share & Trends Analysis Report By Deployment Mode (On-premise, Cloud-based), By Component (Software, Services), By End Use, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

AI-assisted Radiation Therapy Planning Software Market Summary

The global AI-assisted radiation therapy planning software market size was valued at USD 659.6 million in 2025 and is projected to grow from USD 743.5 million in 2026 to USD 1,815.3 million by 2033, at a CAGR of 13.6% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 40.4% in 2025. Growth is driven by the rising prevalence of cancer, the increased demand for precise, personalized radiation therapy, and the broader adoption of artificial intelligence in radiation oncology. AI-assisted software automates treatment planning, contouring, dose optimization, and quality assurance, which improves workflow efficiency and treatment consistency. The expanded use of adaptive radiotherapy, combined with the need to reduce planning time and address anatomical changes during treatment, is also expected to accelerate market growth.

Global AI-assisted Radiation Therapy Planning Software Market Report Segmentation

This report forecasts revenue growth at the global, regional, & country levels and provides an analysis of industry trends in each sub segment from 2021 to 2033. For this study, Grand View Research has segmented the global AI-assisted radiation therapy planning software market report on the basis of deployment mode, component, end use, and region:

  • Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • On-Premise
  • Cloud-Based
  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
    • AI-based treatment planning software
    • Adaptive radiotherapy (ART) software
    • Auto-contouring/auto-segmentation software
    • Dose optimization software
    • Image registration & fusion software
    • Quality assurance (QA) software
  • Services
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Dedicated cancer/oncology treatment centers
  • Ambulatory surgical/radiotherapy centers
  • Others (diagnostic imaging centers, academic & research institutes)
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Product Code: GVR-4-68041-026-9

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Deployment Mode outlook
    • 2.2.2. Component
    • 2.2.3. End Use outlook
  • 2.3. Competitive Insights

Chapter 3. Global AI-assisted Radiation Therapy Planning Software Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Global AI-assisted Radiation Therapy Planning Software: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's five forces analysis
    • 3.3.2. PESTLE Analysis
  • 3.4. Case Studies

Chapter 4. Global AI-assisted Radiation Therapy Planning Software Market Segment Analysis, By Deployment Mode, 2021-2033 (Revenue in USD Million)

  • 4.1. Definition and Scope
  • 4.2. Deployment Mode Market Share Analysis, 2025 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global AI-assisted Radiation Therapy Planning Software Market, by Deployment Mode, 2021 to 2033
    • 4.4.1. On-Premise
      • 4.4.1.1. On-premise market estimates and forecasts 2021 to 2033, (USD Million)
    • 4.4.2. Cloud-Based
      • 4.4.2.1. Cloud-based market estimates and forecasts 2021 to 2033, (USD Million)

Chapter 5. Global AI-assisted Radiation Therapy Planning Software Market Segment Analysis, By Component, 2021-2033 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Component Market Share Analysis, 2025 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global AI-assisted Radiation Therapy Planning Software Market, by Component, 2021 to 2033
  • 5.5. Software
    • 5.5.1. Software market estimates and forecasts 2021 To 2033, (USD Million)
    • 5.5.2. AI-Based Treatment Planning Software
      • 5.5.2.1. AI-based treatment planning software market estimates and forecasts 2021 to 2033, (USD Million)
    • 5.5.3. Adaptive Radiotherapy (ART) Software
      • 5.5.3.1. Adaptive radiotherapy (art) software market estimates and forecasts 2021 to 2033, (USD Million)
    • 5.5.4. Auto-Contouring/Auto-Segmentation Software
      • 5.5.4.1. Auto-contouring/auto- segmentation software market estimates and forecasts 2021 to 2033, (USD Million)
    • 5.5.5. Dose Optimization Software
      • 5.5.5.1. Dose optimization software market estimates and forecasts 2021 to 2033, (USD Million)
    • 5.5.6. Image Registration & Fusion Software
      • 5.5.6.1. Image registration & fusion software market estimates and forecasts 2021 to 2033, (USD Million)
    • 5.5.7. Quality Assurance (QA) Software
      • 5.5.7.1. Quality assurance (QA) software market estimates and forecasts 2021 to 2033, (USD Million)
  • 5.6. Services
    • 5.6.1. Services market estimates and forecasts 2021 to 2033, (USD Million)

Chapter 6. Global AI-assisted Radiation Therapy Planning Software Market Segment Analysis, By End Use, 2021-2033 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. End Use Market Share Analysis, 2025 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Global AI-assisted Radiation Therapy Planning Software Market, by End Use, 2021 to 2033
  • 6.5. Hospitals
    • 6.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD million)
  • 6.6. Dedicated Cancer/Oncology Treatment Centers
    • 6.6.1. Dedicated cancer/oncology treatment centers market estimates and forecasts, 2021 to 2033 (USD million)
  • 6.7. Ambulatory Surgical/Radiotherapy Centers
    • 6.7.1. Ambulatory surgical/radiotherapy centers market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.8. Others (diagnostic imaging centers, academic & research institutes)
    • 6.8.1. Others (diagnostic imaging centers, academic & research institutes) market estimates and forecasts, 2021 to 2033 (USD million)

Chapter 7. AI-assisted Radiation Therapy Planning Software Market Segment Analysis, By Region, 2021- 2033 (USD Million)

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Regional Market Snapshot
  • 7.4. AI-assisted Radiation Therapy Planning Software Market Share by Region, 2025 & 2033:
  • 7.5. North America
    • 7.5.1. North America AI-assisted radiation therapy planning software market, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Scenario
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. U.S. AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Scenario
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Canada AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Scenario
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Mexico AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe AI-assisted Radiation Therapy Planning Software market, 2021 - 2033 (USD Million)
    • 7.6.2. UK
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Scenario
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. UK AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Scenario
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Germany AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Scenario
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. France AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Scenario
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Italy AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Scenario
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Spain AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
    • 7.6.7. Norway
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Scenario
      • 7.6.7.3. Competitive Scenario
      • 7.6.7.4. Norway AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key Country Dynamics
      • 7.6.8.2. Regulatory Scenario
      • 7.6.8.3. Competitive Scenario
      • 7.6.8.4. Sweden AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
    • 7.6.9. Denmark
      • 7.6.9.1. Key Country Dynamics
      • 7.6.9.2. Regulatory Scenario
      • 7.6.9.3. Competitive Scenario
      • 7.6.9.4. Denmark AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Regulatory Scenario
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Japan AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Scenario
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. China AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Scenario
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. India AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Regulatory Scenario
      • 7.7.4.3. Competitive Scenario
      • 7.7.4.4. Australia AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Regulatory Scenario
      • 7.7.5.3. Competitive Scenario
      • 7.7.5.4. South Korea AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Regulatory Scenario
      • 7.7.6.3. Competitive Scenario
      • 7.7.6.4. Thailand AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Regulatory Scenario
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. Brazil AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Scenario
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. Argentina AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key Country Dynamics
      • 7.9.1.2. Regulatory Scenario
      • 7.9.1.3. Competitive Scenario
      • 7.9.1.4. South Africa AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Regulatory Scenario
      • 7.9.2.3. Competitive Scenario
      • 7.9.2.4. Saudi Arabia AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Regulatory Scenario
      • 7.9.3.3. Competitive Scenario
      • 7.9.3.4. UAE AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key Country Dynamics
      • 7.9.4.2. Regulatory Scenario
      • 7.9.4.3. Competitive Scenario
      • 7.9.4.4. Kuwait AI-assisted Radiation Therapy Planning Software Market, 2021 to 2033, (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Commercial Strategies
  • 8.4. Company Profiles
    • 8.4.1. Varian Medical Systems, Inc. (Siemens Healthineers)
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Elekta AB
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. RaySearch Laboratories
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Accuray Incorporated.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Brainlab SE
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. GE HealthCare Technologies Inc.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Koninklijke Philips N.V.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. MVision AI
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Mirada Medical Ltd.
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. DOSIsoft SA
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. Radformation, Inc.
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. TheraPanacea
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
Product Code: GVR-4-68041-026-9

List of Tables

  • Table 1 List of abbreviations'
  • Table 2 List of secondary sources
  • Table 3 North America AI-assisted radiation therapy planning software estimates and forecasts, by country, 2021 - 2033 (USD Million)
  • Table 4 North America AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 5 North America AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 6 North America AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 7 U.S. AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 8 U.S. AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 9 U.S. AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 10 Canada AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 11 Canada AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 12 Canada AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 13 Mexico AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 14 Mexico AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 15 Mexico AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 16 Europe AI-assisted radiation therapy planning software estimates and forecasts, by country, 2021 - 2033 (USD Million)
  • Table 17 Europe AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 18 Europe AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 19 Europe AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 20 UK AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 21 UK AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 22 UK AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 23 Germany AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 24 Germany AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 25 Germany AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 26 France AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 27 France AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 28 France AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 29 Italy AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 30 Italy AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 31 Italy AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 32 Spain AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 33 Spain AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 34 Spain AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 35 Denmark AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 36 Denmark AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 37 Denmark AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 38 Sweden AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 39 Sweden AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 40 Sweden AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 41 Norway AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 42 Norway AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 43 Norway AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific AI-assisted radiation therapy planning software estimates and forecasts, by country, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 48 Japan AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 49 Japan AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 50 Japan AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 51 China AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 52 China AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 53 China AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 54 India AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 55 India AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 56 India AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 57 Australia AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 58 Australia AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 59 Australia AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 60 Thailand AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 61 Thailand AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 62 Thailand AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 63 South Korea AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 64 South Korea AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 65 South Korea AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 66 Latin America AI-assisted radiation therapy planning software estimates and forecasts, by country, 2021 - 2033 (USD Million)
  • Table 67 Latin America AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 68 Latin America AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 69 Latin America AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 70 Brazil AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 71 Brazil AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 72 Brazil AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 73 Argentina AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 74 Argentina AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 75 Argentina AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 76 MEA AI-assisted radiation therapy planning software estimates and forecasts, by country, 2021 - 2033 (USD Million)
  • Table 77 MEA AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 78 MEA AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 79 MEA AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 80 South Africa AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 81 South Africa AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 82 South Africa AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 85 Saudi Arabia AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 86 UAE AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 87 UAE AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 88 UAE AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 89 Kuwait AI-assisted radiation therapy planning software estimates and forecasts, by deployment mode, 2021 - 2033 (USD Million)
  • Table 90 Kuwait AI-assisted radiation therapy planning software estimates and forecasts, by component, 2021 - 2033 (USD Million)
  • Table 91 Kuwait AI-assisted radiation therapy planning software estimates and forecasts, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 AI-assisted radiation therapy planning software market segmentation
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2025)
  • Fig. 10 Market driver relevance analysis (Current & future impact)
  • Fig. 11 Market restraint relevance analysis (Current & future impact)
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 PESTLE analysis
  • Fig. 14 AI-assisted radiation therapy planning software market: deployment mode movement analysis
  • Fig. 15 AI-assisted radiation therapy planning software market deployment mode outlook: Key takeaways
  • Fig. 16 On-premise market, 2021 to 2033 (USD Million)
  • Fig. 17 Cloud-based market, 2021 to 2033 (USD Million)
  • Fig. 18 AI-assisted radiation therapy planning software market: component movement analysis
  • Fig. 19 AI-assisted radiation therapy planning software market component outlook: Key takeaways
  • Fig. 20 Software market, 2021 to 2033 (USD Million)
  • Fig. 21 Services market, 2021 to 2033 (USD Million)
  • Fig. 22 AI-assisted radiation therapy planning software market: end use movement analysis
  • Fig. 23 AI-assisted radiation therapy planning software market end use outlook: Key takeaways
  • Fig. 24 Hospitals market, 2021 to 2033 (USD Million)
  • Fig. 25 Dedicated cancer/oncology treatment market, 2021 to 2033 (USD Million)
  • Fig. 26 Ambulatory surgical/radiotherapy centers market, 2021 to 2033 (USD Million)
  • Fig. 27 Others market, 2021 to 2033 (USD Million)
  • Fig. 28 Regional outlook, 2021 & 2033
  • Fig. 29 Regional market place: Key takeaways
  • Fig. 30 North America AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 31 U.S. AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 32 Canada AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 33 Mexico AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 34 Europe AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 35 UK. AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 36 Germany AI-assisted radiation therapy planning software market, 2021 - 2033 (USD Million)
  • Fig. 37 France AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 38 Italy AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 39 Spain AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 40 Denmark AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 41 Sweden AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 42 Norway AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 43 Asia Pacific AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 44 Japan AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 45 China AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 46 India AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 47 Australia AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 48 Thailand AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 49 South Korea AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 50 Latin America AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 51 Brazil AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 52 Argentina AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 53 MEA AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 54 South Africa AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 55 Saudi Arabia AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 56 UAE AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 57 Kuwait AI-assisted radiation therapy planning software market, 2021 to 2033 (USD Million)
  • Fig. 58 Key company categorization
  • Fig. 59 Strategy mapping
  • Fig. 60 Company market position analysis, 2025
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!